JMCC Group is the leading provider of premium Jamaican medical cannabis products and services to the world. Founded in 2017 and headquartered in Toronto, Canada and Montego Bay, Jamaica, we
are a fully integrated, global medical cannabis company.

Our self-contained supply chain – from propagation and cultivation of raw material supply to product development, manufacturing, packaging and distribution – enables us to manage every step to meet or exceed the highest international standards for quality, security and sustainability.

From the start, our vision has focused on supplying patients everywhere with the highest quality medical products – all made from JMCC’s own GMP- and Organic-certified cannabis, sustainably grown, at an affordable price point. In addition to serving business customers, research partners and patients worldwide from our distribution centres in Australia, Europe and Jamaica, we are proud to be the exclusive Caribbean supplier supporting Project Twenty21. One of the world’s largest observational studies, ProjectTwenty21 is a patient registry initiative organized by the non-profit research organization, Drug Science, in the United Kingdom.